AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2012
Jan 26, 2012
34117_dirs_2012-01-26_99fac3d9-a93e-4ee1-a8bd-fc3e0cdffea3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-10-31
Reporting Person: KRUSOS DENIS A (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-11-05 | Common Stock | G | 500000 | — | Disposed | 1169880 | Direct |
| 2011-02-22 | Common Stock | G | 800000 | — | Disposed | 1169880 | Direct |
| 2011-05-25 | Common Stock | G | 500000 | — | Disposed | 1169880 | Direct |
Footnotes
F1: Amount of securities beneficially owned represents shares held by Denis A. Krusos as of October 31, 2011 and excludes shares Mr. Krusos has the right to acquire upon exercise of stock options pursuant to CopyTele, Inc. stock incentive plans.
F2: Gift.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6